Science & Enterprise subscription

Follow us on Twitter

  • A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its se… https://t.co/gNxQafjlOS
    about 7 hours ago
  • New post on Science and Enterprise: Chip-Based RNA Biotech Raises $60M in Venture Funds https://t.co/rHXkiX4vH7 #Science #Business
    about 7 hours ago
  • An easy-to-use device for measuring intraocular pressure responsible for glaucoma is in development by University o… https://t.co/XNVgZXtsw9
    about 10 hours ago
  • New post on Science and Enterprise: Home Eye Pressure Gauge in the Works https://t.co/5OETI9igDD #Science #Business
    about 11 hours ago
  • A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for de… https://t.co/RG11kdD0as
    about 1 day ago

Please share Science & Enterprise

NIH Trials Testing Covid-19 Blood Clot Therapies

Heart, circulation system

National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections. . . . → Read More: NIH Trials Testing Covid-19 Blood Clot Therapies

Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Syrine ingloved hand

In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Brain Signal Synchronization Device in Development

Brain activity graphic

An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development

NIH Nixes Convalescent Plasma Covid-19 Therapy

Donated plasma

An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections. . . . → Read More: NIH Nixes Convalescent Plasma Covid-19 Therapy

Small Biz Grant Advances Neuro Protection Drugs

Neurons

An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease. . . . → Read More: Small Biz Grant Advances Neuro Protection Drugs

Muti-Focus Contact Lenses Slow Children’s Myopia

Contact lens

Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia

Covid-19 Vaccines, Therapies – 10 August 2020

Covid-19 vaccine and therapy tracker

Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020

NIH Begins Covid-19 Antibody Trials

Global Covid-19

National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials

Trial Set for Covid-19 Antibodies in Long-Term Care

Mobile lab team

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

NIH Issues Contracts for Faster Covid-19 Diagnostics

Accula SARS-CoV-2 test

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics